Literature DB >> 15333263

Tuberculosis along the United States-Mexico border, 1993-2001.

Eileen Schneider1, Kayla F Laserson, Charles D Wells, Marisa Moore.   

Abstract

OBJECTIVES: Tuberculosis (TB) is a leading public health problem and a recognized priority for the federal Governments of both Mexico and the United States of America. The objectives of this research, primarily for the four states in the United States that are along the border with Mexico, were to: (1) describe the epidemiological situation of TB, (2) identify TB risk factors, and (3) discuss tuberculosis program strategies.
METHODS: We analyzed tuberculosis case reports collected from 1993 through 2001 by the tuberculosis surveillance system of the United States. We used those data to compare TB cases mainly among three groups: (1) Mexican-born persons in the four United States border states (Arizona, California, New Mexico, and Texas), (2) persons in those four border states who had been born in the United States, and (3) Mexican-born persons in the 46 other states of the United States, which do not border Mexico.
RESULTS: For the period from 1993 through 2001, of the 16 223 TB cases reported for Mexican-born persons in the United States, 12 450 of them (76.7%) were reported by Arizona, California, New Mexico, and Texas. In those four border states overall in 2001, tuberculosis case rates for Mexican-born persons were 5.0 times as high as the rates for persons born in the United States; those four states have 23 counties that directly border on Mexico, and the ratio in those counties was 5.8. HIV seropositivity, drug and alcohol use, unemployment, and incarceration were significantly less likely to be reported in Mexican-born TB patients from the four border states and the nonborder states than in patients born in the United States from the four border states (P < 0.001). Multivariate analysis revealed that among pulmonary tuberculosis patients who were 18-64 years of age and residing in the four border states, the Mexican-born patients were 3.6 times as likely as the United States-born patients were to have resistance to at least isoniazid and rifampin (i. e., to have multidrug-resistant TB) and twice as likely to have isoniazid resistance. Mexican-born TB patients from the four border states and the nonborder states were significantly more likely to have moved or to be lost to follow-up than were the TB patients born in the United States from the four border states (P < 0.001).
CONCLUSIONS: Increased collaborative tuberculosis control efforts by the federal Governments of both Mexico and the United States along the border that they share are needed if tuberculosis is to be eliminated in the United States.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15333263     DOI: 10.1590/s1020-49892004000700004

Source DB:  PubMed          Journal:  Rev Panam Salud Publica        ISSN: 1020-4989


  16 in total

1.  A new paradigm for quarantine and public health activities at land borders: opportunities and challenges.

Authors:  Stephen H Waterman; Miguel Escobedo; Todd Wilson; Paul J Edelson; Jeffrey W Bethel; Daniel B Fishbein
Journal:  Public Health Rep       Date:  2009 Mar-Apr       Impact factor: 2.792

2.  Development of a Surveillance Definition for United States-Mexico Binational Cases of Tuberculosis.

Authors:  Rachel S Yelk Woodruff; Mark C Miner; Roque Miramontes
Journal:  Public Health Rep       Date:  2018 Mar/Apr       Impact factor: 2.792

3.  HIV-tuberculosis coinfection in Southern California: evaluating disparities in disease burden.

Authors:  Timothy C Rodwell; Richard F W Barnes; Marisa Moore; Steffanie A Strathdee; Annie Raich; Kathleen S Moser; Richard S Garfein
Journal:  Am J Public Health       Date:  2010-02-10       Impact factor: 9.308

4.  Characterizing tuberculosis genotype clusters along the United States-Mexico border.

Authors:  B J Baker; P K Moonan
Journal:  Int J Tuberc Lung Dis       Date:  2014-03       Impact factor: 2.373

5.  Latent tuberculosis among persons at risk for infection with HIV, Tijuana, Mexico.

Authors:  Richard S Garfein; Rafael Laniado-Laborin; Timothy C Rodwell; Remedios Lozada; Robert Deiss; Jose Luis Burgos; Jazmine Cuevas-Mota; Paris Cerecer; Kathleen Moser; Maria Luisa Volker; Steffanie A Strathdee
Journal:  Emerg Infect Dis       Date:  2010-05       Impact factor: 6.883

6.  Tuberculosis testing among populations with high HIV risk in Tijuana, Baja California, Mexico.

Authors:  Michele G Velasquez; Rafael Laniado-Laborin; Timothy C Rodwell; Paris Cerecer; Remedios Lozada; Jazmine Cuevas-Mota; Jose Luis Burgos; Richard S Garfein
Journal:  Rev Panam Salud Publica       Date:  2012-07

7.  Mycobacterium tuberculosis infection among persons who inject drugs in San Diego, California.

Authors:  R F Armenta; K M Collins; S A Strathdee; M A Bulterys; F Munoz; J Cuevas-Mota; P Chiles; R S Garfein
Journal:  Int J Tuberc Lung Dis       Date:  2017-04-01       Impact factor: 2.373

8.  Influences of cross-border mobility on tuberculosis diagnoses and treatment interruption among injection drug users in Tijuana, Mexico.

Authors:  Robert Deiss; Richard S Garfein; Remedios Lozada; Jose Luis Burgos; Kimberly C Brouwer; Kathleen S Moser; Maria Luisa Zuniga; Timothy C Rodwell; Victoria D Ojeda; Steffanie A Strathdee
Journal:  Am J Public Health       Date:  2009-06-18       Impact factor: 9.308

9.  Decline in tuberculosis among Mexico-born persons in the United States, 2000-2010.

Authors:  Brian J Baker; Carla D Jeffries; Patrick K Moonan
Journal:  Ann Am Thorac Soc       Date:  2014-05

10.  Predicting U.S. tuberculosis case counts through 2020.

Authors:  Rachel S Y E L K Woodruff; Carla A Winston; Roque Miramontes
Journal:  PLoS One       Date:  2013-06-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.